NO20070892L - Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse. - Google Patents

Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.

Info

Publication number
NO20070892L
NO20070892L NO20070892A NO20070892A NO20070892L NO 20070892 L NO20070892 L NO 20070892L NO 20070892 A NO20070892 A NO 20070892A NO 20070892 A NO20070892 A NO 20070892A NO 20070892 L NO20070892 L NO 20070892L
Authority
NO
Norway
Prior art keywords
colds
compositions
treatment
glycolylneuraminic acid
glycolylneuraminic
Prior art date
Application number
NO20070892A
Other languages
English (en)
Other versions
NO339920B1 (no
Inventor
Jan Remmereit
Ken Johnson
Original Assignee
Life Science Nutrition As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Science Nutrition As filed Critical Life Science Nutrition As
Publication of NO20070892L publication Critical patent/NO20070892L/no
Publication of NO339920B1 publication Critical patent/NO339920B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20070892A 2004-07-19 2007-02-16 Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse. NO339920B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58904604P 2004-07-19 2004-07-19
US18372105A 2005-07-18 2005-07-18
PCT/US2005/025410 WO2006020210A1 (en) 2004-07-19 2005-07-19 Ngna compositions and methods of use

Publications (2)

Publication Number Publication Date
NO20070892L true NO20070892L (no) 2007-04-11
NO339920B1 NO339920B1 (no) 2017-02-13

Family

ID=35907728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070892A NO339920B1 (no) 2004-07-19 2007-02-16 Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.

Country Status (6)

Country Link
US (4) US8535732B2 (no)
EP (1) EP1773363A4 (no)
AU (2) AU2005274824A1 (no)
CA (1) CA2574721C (no)
NO (1) NO339920B1 (no)
WO (1) WO2006020210A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2574721C (en) 2004-07-19 2011-06-07 Life Science Nutrition As Ngna compositions and methods of use
US20080081826A1 (en) * 2006-04-28 2008-04-03 Springuel Damien P System for effecting weight loss
US20100119558A1 (en) * 2008-11-10 2010-05-13 Scandivir Ab Ngna compositions and methods of use
US8697670B2 (en) 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
AU2012251422B2 (en) * 2011-05-05 2015-05-21 Life Science Nutrition As Performance enhancing compositions and methods of use
EP3319592A1 (en) * 2015-07-07 2018-05-16 perora GmbH Method of inducing satiety
WO2017060498A1 (en) * 2015-10-09 2017-04-13 Universität Zürich N-glycolyneuraminic acid for the prevention or treatment of asthma and allergy
CN109845956A (zh) * 2018-12-20 2019-06-07 北京长生堂国际中医药研究院 一种复合代餐粉及其生产方法
CN115869205A (zh) * 2021-09-27 2023-03-31 嘉必优生物技术（武汉）股份有限公司 抗非酶糖基化组合物及其应用、非酶糖基化抑制剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038697A1 (en) * 1998-12-29 2000-07-06 Glukor, Inc. Treatment and prevention of hiv and other viral infections
WO2001042263A2 (de) * 1999-12-07 2001-06-14 N.V. Nutricia Oligosaccharidmischung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358939A3 (de) * 1988-08-12 1991-07-24 Hoechst Aktiengesellschaft Pilz-lysierendes Enzymprodukt aus Streptomyceten, dessen Herstellung und Verwendung
JP2798287B2 (ja) * 1989-02-08 1998-09-17 ユニチカ株式会社 抗炎症剤
JPH0484872A (ja) * 1990-07-26 1992-03-18 Hodaka Kanko Shokuhin:Kk 薬膳顆粒の製造法
JP3211191B2 (ja) * 1992-03-31 2001-09-25 太陽化学株式会社 茶抽出物組成物
JPH05278264A (ja) 1992-03-31 1993-10-26 Toshiba Corp 光プリントヘッド
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
NL9201842A (nl) * 1992-10-23 1994-05-16 Teng Hian Khoe Toepassing van een papaine bevattend voedingssupplement voor therapeutische behandeling van AIDS aandoeningen.
US5985330A (en) * 1996-08-05 1999-11-16 Coastside Bio Resources Inhibition of angiogenesis by sea cucumber fractions
WO1998044946A1 (en) * 1997-04-04 1998-10-15 Obetech, Llc Viral obesity methods and compositions
CA2227688C (en) * 1998-01-16 2007-07-31 James W. Critchfield Methods and compositions for inhibition of viral replication
US20050201952A1 (en) * 1998-01-29 2005-09-15 Yash Sharma Treatment and prevention of viral hepatitis infections
US20050148541A1 (en) * 1998-01-29 2005-07-07 Yash Sharma Treatment and prevention of HIV and other viral infections
US20020103139A1 (en) * 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
EP1482909B1 (en) * 2002-02-13 2018-07-04 Creagri, Inc. Method and composition for treatment of inflammation
CA2574721C (en) 2004-07-19 2011-06-07 Life Science Nutrition As Ngna compositions and methods of use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000038697A1 (en) * 1998-12-29 2000-07-06 Glukor, Inc. Treatment and prevention of hiv and other viral infections
WO2001042263A2 (de) * 1999-12-07 2001-06-14 N.V. Nutricia Oligosaccharidmischung

Also Published As

Publication number Publication date
US8535732B2 (en) 2013-09-17
CA2574721C (en) 2011-06-07
US20090221526A1 (en) 2009-09-03
US8741361B2 (en) 2014-06-03
AU2009222618B2 (en) 2012-12-13
WO2006020210A1 (en) 2006-02-23
US20140024607A1 (en) 2014-01-23
US20140271906A1 (en) 2014-09-18
CA2574721A1 (en) 2006-02-23
US20060193907A1 (en) 2006-08-31
AU2005274824A1 (en) 2006-02-23
AU2009222618A1 (en) 2009-10-29
NO339920B1 (no) 2017-02-13
EP1773363A1 (en) 2007-04-18
US9144577B2 (en) 2015-09-29
US7901715B2 (en) 2011-03-08
EP1773363A4 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
NO20070892L (no) Sammensetninger av N-glykolylneuraminsyre og anvendelse derav ved behandling av forkjølelse.
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
DK1773361T4 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
DK1765376T3 (da) Topiske sammensætninger og anvendelse deraf til behandling af epitel-relaterede tilstande
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
GB2414933B (en) Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
IL192198A0 (en) Skin care compositions and treatments
EP1928453A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RENAL DISEASES
EP2185202A4 (en) USE OF INTERLEUKIN-22 FOR THE TREATMENT OF FATTLEBER
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
DK2465493T3 (da) Topiske sammensætninger til forebyggelsen og behandlingen af irritation af mukøse celler
DK1750713T3 (da) Anvendelse af imatinib til behandling af leversygdomme og vi-rusinfektioner
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
IL190969A0 (en) Pyrazoles useful in the treatment of inflammation
EP1720563A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION
DK1984014T3 (da) Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi
DK1933840T3 (da) Anvendelse af delmopinol i behandlingen af acne
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
IL195155A (en) Dosage form for delayed glucocorticoid release and its use in the treatment of rheumatic diseases
FR2905270B1 (fr) Utilisation de sucres en c7 dans la prevention et le traitement des mycoses
GB2411834B (en) Composition for use in the treatment of dry skin conditions